oral glp-1 drugs in development The challenge of developing alternatives to Ozempic, Wegovy and Mounjaro The Great (Oral) GLP-1 Scare

Feist Cardiovascular Research Fellowship to RP and the Endowed Chair in Diabetes to SKJ from the Center for Cardiovascular Diseases and Sciences (CCDS), LSUHSC, Shreveport, as well as grants to SKJ from the National Institutes of Health/National Center for Complementary and Integrative Health (RO1 AT007442, 2013-16)

A 500 mcg dose from a verified 503A pharmacy delivers 500 mcg of active peptide

capillary voltage, 4500 V

Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects

The Most Favored Nation initiative has so far resulted in agreements with Pfizer, AstraZeneca and other companies to sell certain products directly to consumers at a reduced price often in exchange for relief from the threat of targeted tariffs